Page last updated: 2024-10-21

phenytoin and Parkinson Disease, Postencephalitic

phenytoin has been researched along with Parkinson Disease, Postencephalitic in 1 studies

Parkinson Disease, Postencephalitic: Parkinsonism following encephalitis, historically seen as a sequella of encephalitis lethargica (Von Economo Encephalitis). The early age of onset, the rapid progression of symptoms followed by stabilization, and the presence of a variety of other neurological disorders (e.g., sociopathic behavior; TICS; MUSCLE SPASMS; oculogyric crises; hyperphagia; and bizarre movements) distinguish this condition from primary PARKINSON DISEASE. Pathologic features include neuronal loss and gliosis concentrated in the MESENCEPHALON; SUBTHALAMUS; and HYPOTHALAMUS. (From Adams et al., Principles of Neurology, 6th ed, p754)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fahn, S1
Craddock, G1
Kumin, G1

Other Studies

1 other study available for phenytoin and Parkinson Disease, Postencephalitic

ArticleYear
Acute toxic psychosis from suicidal overdosage of amantadine.
    Archives of neurology, 1971, Volume: 25, Issue:1

    Topics: Acute Disease; Amantadine; Blood-Brain Barrier; Chlorpromazine; Humans; Male; Middle Aged; Parkinson

1971